Literature DB >> 6967729

HLA-DRw3 and systemic lupus erythematosus.

O Scherak, J S Smolen, W R Mayr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967729     DOI: 10.1002/art.1780230815

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Primary biliary cirrhosis associated with features of systemic lupus erythematosus.

Authors:  G D Iliffe; S Naidoo; T Hunter
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

2.  Neonatal lupus erythematosus: five new cases with HLA typing.

Authors:  K A Barber; R Jackson
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

3.  HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.

Authors:  J S Smolen; J H Klippel; E Penner; M Reichlin; A D Steinberg; T M Chused; O Scherak; W Graninger; E Hartter; C C Zielinski
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

4.  HLA DR antigens and gold toxicity.

Authors:  J T Gran; G Husby; E Thorsby
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

5.  Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: correlation with clinical and immunological parameters.

Authors:  J S Smolen; G Lanzer; O Scherak; E J Menzel; W R Mayr; C Steffen; W Knapp
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

Review 6.  Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.

Authors:  Manfred Relle; Andreas Schwarting
Journal:  Clin Dev Immunol       Date:  2012-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.